US Patent Issued to UNIVERSITEIT ANTWERPEN on Oct. 14 for "Anti-pathogenic activity of a bifunctional peptidoglycan/chitin hydrolase" (Belgian Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,439,925, issued on Oct. 14, was assigned to UNIVERSITEIT ANTWERPEN (Antwerp, Belgium).

"Anti-pathogenic activity of a bifunctional peptidoglycan/chitin hydrolase" was invented by Camille Allonsius (Antwerp, Belgium) and Sarah Lebeer (Mortsel, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention generally relates to the use of a bifunctional peptidoglycan/chitin hydrolase to reduce and/or prevent hyphae formation in a pathogen, and/or to reduce or prevent biofilm formation. The present invention further relates to a bifunctional peptidoglycan/chitin hydrolase for use in the treatment and/or prevention of pathogenic infections, in ...